VIM
UTHR icon

Vinva Investment Management’s United Therapeutics UTHR Stock Holding History

Vinva Investment Management’s Portfolio UTHR Stock Details UTHR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$40.4M Buy
68,608
+19,649
+40% +$9.79M 0.5% 43
2025
Q4 		$24.3M Buy
48,959
+23,995
+96% +$11.2M 0.3% 81
2025
Q3 		$10.6M Sell
24,964
-14,502
-37% -$4.88M 0.21% 127
2025
Q2 		$11.2M Buy
39,466
+30,734
+352% +$9.19M 0.29% 88
2025
Q1 		$2.68M Sell
8,732
-10,792
-55% -$3.7M 0.11% 195
2024
Q4 		$6.98M Sell
19,524
-10,085
-34% -$3.71M 0.27% 85
2024
Q3 		$10.6M Sell
29,609
-5,294
-15% -$1.79M 0.45% 50
2024
Q2 		$11.2M Buy
34,903
+14,829
+74% +$3.92M 0.56% 32
2024
Q1 		$4.61M Buy
20,074
+11,727
+140% +$2.65M 0.26% 100
2023
Q4 		$1.83M Buy
8,347
+2,914
+54% +$672K 0.12% 188
2023
Q3 		$1.23M Buy
5,433
+4,258
+362% +$981K 0.11% 185
2023
Q2 		$258K Sell
1,175
-130
-10% -$28.8K 0.02% 355
2023
Q1 		$286K Buy
+1,305
New +$322K 0.02% 371

Other funds holding UTHR

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
ACA
Avoro Capital Advisors New York $10.2B AUM 149.19% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $218B AUM 29.41% 1-Year Est. Return

Vinva Investment Management's UTHR Position: Q1 2026 in Review

Vinva Investment Management increased its United Therapeutics (UTHR) stake by 40% in Q1 2026, buying an estimated $9.79M and bringing the position to 68,608 shares worth $40.4M. The position accounts for 0.5% of the portfolio, ranked #43.

Vinva Investment Management first reported a position in UTHR in Q1 2023 and has held it in 13 quarters since. 852 funds tracked by Wall St. Rank hold UTHR as of Q1 2026.

  • Vinva Investment Management held 68,608 shares of United Therapeutics worth $40.4M as of Q1 2026.
  • Vinva Investment Management bought 19,649 United Therapeutics shares in Q1 2026, an estimated $9.79M.
  • United Therapeutics made up 0.5% of Vinva Investment Management's portfolio in Q1 2026, its #43 holding.
  • Vinva Investment Management first reported a position in United Therapeutics in Q1 2023 and has held it in 13 quarters since.
  • 852 funds tracked by Wall St. Rank held United Therapeutics as of Q1 2026.

Based on Vinva Investment Management's 13F filing for Q1 2026, filed 14 May 2026.